23 results on '"Machado, Adriana"'
Search Results
2. DERMATOMYOSITIS AFTER COVID-19 VACCINATION: TWO CASES REPORT
3. CARDIOVASCULAR RISK IN SJÖGREN S DISEASE FROM THE BRAZILIAN SJÖGREN S DISEASE REGISTRY (REBRAS)
4. CORRELATION BETWEEN SALIVARY GLANDS ULTRASONOGRAPHY WITH CLINICAL DATA IN PATIENTS WITH PRIMARY SJOGREN S DISEASE
5. ACUTE FIBRINOUS AND ORGANIZING PNEUMONIA INDUCED BY RITUXIMAB REPORT OF TWO CASES
6. POSITIVITY OF ANTI-LA/SSB ANTIBODIES IN SJÖGREN S DISEASE IS ASSOCIATED WITH EXTRA-GLANDULAR SYSTEMIC MANIFESTATION: RESULTS FROM THE THE BRAZILIAN SJÖGREN S DISEASE REGISTRY (REBRAS)
7. SCHIRMER TEST, VAN BIJSTERVELD, OSS, AND BREAK-UP TIME TEST IN PRIMARY SJOGREN S SYNDROME
8. MIKULICZ S DISEASE AS MANIFESTATION OF IGG4 - RELATED DISEASES CASE REPORT
9. THYMOMA IN AUTOIMMUNE RHEUMATOLOGICAL DISEASES ASSOCIATION IN TWO CASES
10. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING CYCLOPHOSPHAMIDE. CASE REPORT
11. Immunobiological therapy as a treatment option for patients with systemic vasculitis: clinical profile of patients in a tertiary health care center.
12. AGEUSIA AND ANOSMIA, A SIDE EFFECT OF LEFLUNOMIDE
13. MACROPHAGE ACTIVATION SYNDROME PRESENTING AS THE FIRST MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS: CASE REPORT AND LITERATURE REVIEW
14. Epidemiological profile of patients using janus kinase inhibitors in a tertiary center.
15. Crowned Dens Syndrome (CDS) in Calcium Pyrophosphate Deposition Disease (CPPD): rare or underdiagnosed entity?
16. EVALUATION OF THE NOCEBO EFFECT OF PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE SWITCHED THE ADMINISTRATION ROUT FROM THE ENDOVENOUS ABATACEPT TO SUBCUTANEOUS
17. Epidemiological profile of patients with Calcium Pyrophosphate Deposition (CPPD) Disease at a Tertiary Hospital
18. Qualificação Docente: capacitação para utilização do Google Classroom em meio à pandemia de COVID-19
19. Inappropriate sleep time trajectories from adolescence to early adulthood: an analysis from a Brazilian birth cohort
20. EFFECTIVENESS AND SAFETY OF ABATACEPT FOR 24 MONTHS FOR TREATING PATIENTS WITH PRIMARY SJOGREN’S SYNDROME (PSS)
21. THE RISK OF CANCER DEVELOPMENT IN SJOGREN SYNDROME
22. AB0464 EFFECTIVENESS AND SAFETY OF ABATACEPT FOR 24 MONTHS FOR TREATING PATIENTS WITH PRIMARY SJOGREN’S SYNDROME (PSS)
23. USINA-ESCOLA DE FERRO-GUSA VERDE: USO DE B-LEARNING E REALIDADE VIRTUAL COMO PLATAFORMA DE EDUCAÇÃO PROFISSIONAL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.